Company: OCEA
Filing Date: 2025-01-13
Form Type: 10-Q
Source: 0001493152-25-001880
Chunk: 34

Company: Ocean Biomedical, Inc.
Filing Date: 2025-01-13
Form: 10-Q
Item: Item 1
Chunk 34
---
 (10) 
     (1,168) 
     269 
  
    Balance as of December 31, 2023 
     (58,523) 
     (4,123) 
     (5,618) 
     (764) 
     - 
  
    Changes in fair value thru July 15, 2024 
     -  
     -  
     (681) 
     (824) 
     - 
  
    Balance as of July 15, 2024 
     (58,523) 
     (4,123) 
     (6,299) 
     (1,588) 
     - 
  
    Balance 
     (58,523) 
     (4,123) 
     (6,299) 
     (1,588) 
     - 

    Effect of Note Exchange 
     -  
     -  
     (504) 
     (2,171) 
     - 
  
    Additional 2024 Notes issued 
     -  
     -  
     (968) 
     -  
     - 
  
    Changes in fair value 
     1,482  
     (1,040) 
     (142) 
     186  
     - 
  
    Balance as of September 30, 2024 
     (57,041) 
     (5,163) 
     (7,913) 
     (3,573) 
     - 
  
    Balance 
     (57,041) 
     (5,163) 
     (7,913) 
     (3,573) 
     - 

    18

5.
Accounts Payable and Accrued Expenses

Accounts
payable and accrued expenses consisted of the following:

Schedule of Accounts Payable and Accrued Expenses

    (in thousands) 
    September 30, 2024  
    December 31, 2023 
  
    Accounts payable and accrued expenses: 

    Accounting and legal fees 
    $12,081  
    $12,099 
  
    Vendor fees 
     2,980  
     2,517 
  
    Research and development 
     647